// App-Quantinova.ai

Abstract 13834 : The Effect of Dapagliflozin on Serum Uric Acid in Heart Failure With Reduced Ejection Fraction: Insights From DAPA-HF

Researchers

Presenter

  • Kieran F Docherty

Principal Investigators

  • Paul WELSH

  • David Morrow

  • Pardeep S Jhund

  • Naveed Sattar

  • Ann Hammarstedt

  • Anna Maria Langkilde

  • Marc S Sabatine

  • John J McMurray

Medical Centers

  • lndal, Sweden

  • ASTRAZENECA, M Lndal, Sweden

  • BHF CARDIOVASCULAR RESEARCH CENTRE, Glasgow, United Kingdom

  • BHF CARDIOVASCULAR RESEARCH CENTRE, Glasgow

  • UNIVERSITY OF GLASGOW, Glasgow

  • TIMI Study Group, Boston, MA

Locations

  • Sweden

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart failure with reduced ejection fraction

  • Congestive heart failure

Biomarkers

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Dapagliflozin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved